糖尿病血液採集設備市場規模、佔有率和成長分析：按產品組合、血液採集部位、最終用戶、銷售管道、分銷管道和地區分類－2026-2033年產業預測

2024 年全球糖尿病採血設備市場價值為 10.2 億美元，預計到 2025 年將成長至 11.2 億美元，到 2033 年將成長至 24.6 億美元，在預測期（2026-2033 年）內複合年成長率為 10.28%。

全球糖尿病採血針市場的主要驅動力是糖尿病盛行率的不斷上升以及人們對自我管理的日益重視。隨著患者數量的增加，對易於使用、疼痛感更低的採血方法的需求也隨之成長。這一領域涵蓋一次性採血針、筆式採血針以及可調節穿刺深度的採血系統，所有這些產品都能提高採血依從性，促進血糖控制，並最終降低長期併發症和醫療成本。可調式採血針、符合人體工學的設計以及安全功能等創新技術正在提高使用者接受度和檢測頻率。此外，將數位技術整合到採血設備中，為增強數據管理和遠端醫療解決方案創造了機遇，尤其是在發展中地區，為全面的糖尿病監測和篩檢計畫鋪平了道路。

全球糖尿病採血針市場成長要素

全球糖尿病盛行率的不斷上升導致需要持續血糖監測的人數顯著增加，進而推動了對糖尿病採血針的需求。患者尋求舒適、安全且易於使用的採血方式，而醫療專業人員在推薦產品時也強調易用性和依從性的重要性。這種關注促使製造商拓展產品線，生產各種尺寸的採血針，並擴大其在更多地區的供應。此外，以病人為中心的配送模式也日益受到醫療專業人員的倡導，這敦促製造商進一步改善採血針的種類和供應。

全球糖尿病採血針市場的限制因素

全球糖尿病採血針市場面臨許多限制因素，主要原因是病患和看護者在購買改良型品牌採血針時需要承擔高昂的自付費用。這種經濟負擔往往導致他們不願意定期更換採血針，影響使用者的安全性和舒適度。患者通常優先考慮必需的藥物和醫療用品，而不是購買先進的採血針，這導致他們無法及時更新採血針，或被迫選擇價格更低、功能欠佳的替代品。因此，這種趨勢降低了高級產品的吸引力，限制了製造商的收入潛力，並影響了整體市場成長。

糖尿病穿刺裝置的全球市場趨勢

全球糖尿病穿刺器械市場正呈現向醫療生態系統數位化整合的顯著趨勢。製造商正擴大將網際網路連接和協作平台整合到其設備中，以加強慢性病管理。這種整合實現了數據與行動應用程式和醫療記錄的無縫傳輸，從而改善了遠端患者監護和醫護人員互動，並提高了患者依從性。為了脫穎而出，各公司正與數位醫療供應商建立策略合作夥伴關係，並強調以用戶為中心的設計，以提升整體用戶體驗。因此，市場正朝著支持持續護理、個人化回饋和加強跨醫療機構協作的整合解決方案轉型。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球糖尿病血液採集設備市場規模：依產品組合分類。

• 可重複使用的穿刺裝置
• 免洗安全採血針裝置

全球糖尿病採血設備市場規模：依穿刺部位分類

• 指尖測試裝置
• 用於替代場地檢查的設備

全球糖尿病血液採樣設備市場規模：依最終用戶分類

• 居家照護環境
• 醫院和診所
• 診斷和病理檢查室

全球糖尿病血液採樣設備市場規模：依銷售管道分類

• 線上
• 離線

全球糖尿病血液採樣設備市場規模：依通路分類

• 直接的
• 間接

全球糖尿病血液採集設備市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• F. Hoffmann-La Roche
• Lifescan
• Abbott Laboratories
• Ascensia Diabetes Care
• Becton Dickinson
• Terumo Corporation
• Ypsomed Holding
• Arkray
• Trividia Health
• Owen Mumford
• HTL-Strefa
• Sarstedt
• Greiner Bio-One
• Medline Industries
• Cardinal Health
• Owens & Minor
• Sinocare
• i-Sens
• Allmed Medical Products
• AgaMatrix

結論與建議

Global Diabetic Lancing Device Market size was valued at USD 1.02 Billion in 2024 and is poised to grow from USD 1.12 Billion in 2025 to USD 2.46 Billion by 2033, growing at a CAGR of 10.28% during the forecast period (2026-2033).

The global market for diabetic lancing devices is primarily driven by the increasing prevalence of diabetes and a heightened focus on self-monitoring. As the patient population expands, there is a growing demand for accessible and less painful blood sampling methods. This sector encompasses disposable lancets, pen lancing devices, and adjustable depth systems, all of which enhance sampling adherence and promote better glycemic control, ultimately reducing long-term complications and healthcare costs. Innovations such as variable depth lancets, ergonomic designs, and safety features are boosting user acceptance and frequency of testing. Additionally, the integration of digital technology with lancing devices presents opportunities for enhanced data management and telemedicine solutions, particularly in developing regions, offering a pathway for comprehensive diabetes monitoring and screening initiatives.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Diabetic Lancing Device market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Diabetic Lancing Device Market Segments Analysis

Global diabetic lancing device market is segmented by product configuration portfolio, target penetration site, end-user, sales channel, distribution channel and region. Based on product configuration portfolio, the market is segmented into reusable lancing devices and disposable safety lancing devices. Based on target penetration site, the market is segmented into fingertip testing devices and alternate site testing devices. Based on end-user, the market is segmented into homecare settings, hospitals & clinics and diagnostic & pathology laboratories. Based on sales channel, the market is segmented into online and offline. based on distribution channel, the market is segmented into direct and indirect. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Diabetic Lancing Device Market

The rising prevalence of diabetes worldwide has resulted in a significant increase in the number of individuals needing consistent blood glucose monitoring, subsequently driving the demand for diabetic lancing devices. As patients require comfortable, safe, and user-friendly options for obtaining blood samples, healthcare professionals emphasize the importance of ease-of-use and adherence when advising on products. This focus encourages manufacturers to diversify their offerings, producing devices in various sizes and making them available in more locations. Furthermore, healthcare providers are increasingly advocating for patient-centered distribution approaches, which further incentivizes manufacturers to enhance the variety and accessibility of their lancing devices.

Restraints in the Global Diabetic Lancing Device Market

The global diabetic lancing device market faces significant constraints stemming from the challenges patients and caregivers encounter in acquiring upgraded or branded devices, primarily due to their high out-of-pocket costs. This financial burden often leads to reluctance in regularly replacing devices, thereby compromising both safety and comfort for users. Patients tend to prioritize essential medications and supplies over the purchase of advanced lancing devices, which can delay upgrades or result in the selection of less expensive, suboptimal options that lack advanced features. Consequently, this trend diminishes the appeal of premium products, restricting manufacturers' revenue potential and impacting overall market growth.

Market Trends of the Global Diabetic Lancing Device Market

The Global Diabetic Lancing Device market is witnessing a significant trend toward digital integration within care ecosystems. Manufacturers are increasingly incorporating Internet connectivity and collaborative platforms into their devices to enhance the management of chronic diseases. This integration facilitates seamless data transfer to mobile applications and health records, thereby improving remote patient monitoring and clinician engagement while boosting patient compliance. To stand out, companies are forming strategic partnerships with digital health vendors and emphasizing user-centered design, enhancing the overall user experience. As a result, the market is leaning toward integrated solutions that support continuous care, personalized feedback, and better coordination across various healthcare settings.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Diabetic Lancing Device Market Size by Product Configuration Portfolio & CAGR (2026-2033)

• Market Overview
• Reusable Lancing Devices
• Disposable Safety Lancing Devices

Global Diabetic Lancing Device Market Size by Target Penetration Site & CAGR (2026-2033)

• Market Overview
• Fingertip Testing Devices
• Alternate Site Testing Devices

Global Diabetic Lancing Device Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Homecare Settings
• Hospitals & Clinics
• Diagnostic & Pathology Laboratories

Global Diabetic Lancing Device Market Size by Sales Channel & CAGR (2026-2033)

• Market Overview
• Online
• Offline

Global Diabetic Lancing Device Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct
• Indirect

Global Diabetic Lancing Device Market Size & CAGR (2026-2033)

• North America (Product Configuration Portfolio, Target Penetration Site, End-User, Sales Channel, Distribution Channel)
  • US
  • Canada
• Europe (Product Configuration Portfolio, Target Penetration Site, End-User, Sales Channel, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Configuration Portfolio, Target Penetration Site, End-User, Sales Channel, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Configuration Portfolio, Target Penetration Site, End-User, Sales Channel, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Configuration Portfolio, Target Penetration Site, End-User, Sales Channel, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• F. Hoffmann-La Roche
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifescan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ascensia Diabetes Care
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holding
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arkray
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trividia Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Owen Mumford
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HTL-Strefa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sarstedt
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Greiner Bio-One
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medline Industries
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Owens & Minor
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinocare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• i-Sens
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allmed Medical Products
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AgaMatrix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations